Advanced prostate cancer – patient survival and potential impact of enzalutamide and other emerging therapies
Nihar K Patel, Antoine Finianos, Kristen D Whitaker, Jeanny B Aragon-Ching Department of Medicine, Division of Hematology and Oncology, George Washington University Medical Center, Washington, DC, USA Abstract: The advent of exponential growth of novel agents tested and approved for the treatment...
Main Authors: | Patel NK, Finianos A, Whitaker KD, Aragon-Ching JB |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2014-08-01
|
Series: | Therapeutics and Clinical Risk Management |
Online Access: | http://www.dovepress.com/advanced-prostate-cancer-ndash-patient-survival-and-potential-impact-o-peer-reviewed-article-TCRM |
Similar Items
-
Metastatic Castration-Resistant Prostate Cancer: Critical Review of Enzalutamide
by: Joelle El-Amm, et al.
Published: (2013-08-01) -
Metastatic Castration-Resistant Prostate Cancer: Critical Review of Enzalutamide
by: Joelle El-Amm, et al.
Published: (2013-01-01) -
Erratum for “Metastatic Castration-Resistant Prostate Cancer: Critical Review of Enzalutamide”
by: Joelle El-Amm, et al.
Published: (2013-11-01) -
Erratum for “Metastatic Castration-Resistant Prostate Cancer: Critical Review of Enzalutamide”
by: Joelle El-Amm, et al.
Published: (2013-01-01) -
Enzalutamide as a second generation antiandrogen for treatment of advanced prostate cancer
by: Semenas J, et al.
Published: (2013-08-01)